This recent acquisition I decided to go with the very famous and beloved by dividend growth investors, Johnson & Johnson (JNJ). Very hard to resist such a premium company trading near 16 P/E. It has done great over the years returning capital to shareholders and with their low payout ratio I foresee more of that coming. Additionally, this dividend growth aristocrat has been raising their dividend every single year since 1963.
Founded in 1885, Johnson & Johnson is a major leading healthcare holding company that researches, develop, manufactures and sells a variety of products worldwide. The company operates primarily in three segments, consumer, pharmaceutical and medical devices. It has a wide diversification of products that it distributes to the general public through retail outlets, distributors, wholesalers, hospitals, and health care professionals. Some of these products are prescription and non prescription based. Though, you might see the majority of the companies products in hospitals or other health institution environments used by physicians, nurses and other medical professionals.
- Dividend Yield: 3.2%
- 3 Year Dividend Growth Rate: 7%
- Payout Ratio: 48.7%
- P/E: 16.3
- Consecutive Years of Dividend Raises: 52
I purchased 10 shares of JNJ for the price of $91.40 adding $30.00 to my annual dividend income.
This is the 10th time I am initiating a stock acquisition this year. This transaction is my additional purchase of JNJ shares into the portfolio. As of today, I hold 35 shares of JNJ. Currently, JNJ ownership stake represents to be around 5.1% of my current portfolio value.
The 12-month dividend income increased to $2,478.
Thank you for reading & have a great day!